Evolution of microelectrode array plates fabricated at UNT

 

56 mm

 

 

 

 

 

 

 

 

 

50 mm

50 mm

MMEP 4  1986

MMEP 5 1997

MMEP 6  1999

 

 

90

MMEP 8 (2005)

Electrode spacing: 200

m

m     

Field separation: 2 mm

Edge contacts: 300

m

m         

Pitch 300

m

m

Electrode spacing: 200

m

m     

Field separation: 2 mm

GND

GND

Edge contacts: 300

m

m         

Pitch 300

m

m

MMEP 8.256: Same plate as MMEP-8 but with all 256 electrodes located in a center area to record from one network. Amplifier contacts are also the same, allowing use of common electronic data acquisition equipment.

Plate dimensions: 56 x 90 mm


All plates consist of optically flat glass and transparent indium-tin oxide conductors.  Plates are spin insulated with methyltrimethoxysilane resin and de-insulated at the tips of the conductors with single laser shots.  Except for the masks, all fabrication is performed by students working with the Center. 

MMEP 8.256  May 06


 

MMEP 4:  64 microelectrodes arranged in an 8 x 8 format with equal electrode separation of 150 um.

MMEP 5:  64 microelectrodes serving two separate recording matrices of 32 electrodes each.

MMEP 6:  64 microelectrodes arranged to form three recording areas with 16 electrodes each connected

by two linear conduits each with 8 electrodes.

NOTE:  MMEPs 4-6 have the same amplifier connections

MMEP 8:  8-network plate with 32 electrodes per recording matrix. Compatible with Plexon Inc. 256 preamplifier circuit board.


 

 

Summary of Methods and Examples of Results

A

C

D

B

 

 

 

 


 

 

 

 

 

 

 

 

 

Figure 1. Examples of neuronal circuits on microelectrode arrays.  Transparent conductors allow extensive optical access to the network morphology.  (A) Neuronal network derived from murine spinal cord tissue (98 days in vitro), grown on the recording matrix of a 64-electrode array plate.  Bodian stain.  (B-D) Living neurons on MEAs  Gold-plated exposed ITO conductors are shown by arrows in (B). The conductors are 8 mm wide. (all bars = 40 mm).

 

Figure 2.  (Right) Electronic display of time stamp patterns (A), waveforms (B), and electrode layout (C). (Plexon  Inc., Dallas).

 

EXAMPLE 1.  Zinc Toxicity (Parviz, M. and Gross, G.W.  (2007)  Quantification of zinc toxicity using neuronal networks on microelectrode arrays.   NeuroToxicology 28: 520-531.)

Figure 3. (A) Common network response to high concentra-tions of zinc. Each data point represents the average spike (left ordinate) and burst (right ordinate) rate in 1 min bins for all discriminated units.  Addition of 200 mM zinc at 38 min results in an immediate excitatory period lasting 70 min followed by activity decay for about 30 min and complete, irreversible activity loss. (B1-B6) Consecutive pictures of the same neuron taken at approximately 30 min intervals.  At 220 min (B6, right panel), the neuron is swollen and necrotic in appearance.

 

B11

B222

B333

B44

B55

B6

A

B1

B5

 

 

 

 

 

 

 

 


Figure 4 (below). Pooled data from spinal cord and frontal cortex cultures.  A double log plot reveals linear functions for 50% and 90% activity decreases. All experiments (n=23) were conducted in serum-free and albumin-free medium.  Activity losses were irreversible.


DMEA+O-CO-S(CH2)4S-CO-DMEA+

Ch+O-CO-S(CH2)6S-CO-OCh+

 

Screening of 7 newly synthesized weak AChE blockers for alleviation of Alzheimer’s syndrome synthesized at the University of Perugia, Italy by Prof. Vincenzo Talesa.

 

BIOCHEMICAL DATA CONFIRMED BINDING TO AChE.

However, two out of seven compounds were irreversible inhibitors of activity (unexpected secondary binding.)

 

Keefer, E.W., Norton, S.J., Boyle, N.A.J., Talesa, V., and Gross, G.W. (2001)  Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays.  NeuroToxicology 22: 3-12.

 

Figure 5.  Desired spike and burst response profiles activity increases at defined concentrations with reversible toxicity at higher concentrations.  Such drug efficacy range information can be obtained in a few hours and used to guide and minimized subsequent animal experiments.

Figure 6. Unexpected irrever-sible toxic effect at 300 mM.  Activity could not be recovered by three medium changes and during 24 hr monitoring.

EXAMPLE 2. Screening Novel AChE Blockers


                       

Comparison of ethanol effects on mammals and FC cultures

Mammal              Conc.                                       Effect                                    

humans           5-15          slight impairment of attention and judgment

humans           10-22       impairment of speech and balance

humans           15-30       significant sedation

rats                   20             sedation

FC cultures    10             first measurable change in activity pattern

                                            (slight) excitation

FC cultures    15             first overt change in spike and burst production

                                            (inhibition)

humans           30-55       mental confusion

mice                 40             loss of righting reflex

FC cultures    48.8          EC50 for spike production

humans           100           coma and death

mice                 120           coma, hypothermia

FC cultures    100-140   cessation of all spontaneous activity

_________________________________________________________

(human and animal data from Charness et al., 1989; Little, 1991). 

FC: frontal cortex cultures

 

EC50: 48.8 mM

Fig. 7.  (A) Responses of networks to low and high concentrations of ethanol.  160 mM (60 mM past coma) for  2 hr exposures are still reversible.  (B) Dose response curves from five networks. The mean EC50 is 48.8±5.4 mM.  (C) Table comparing responses to alcohol for humans, mice, and mouse networks in vitro.

A

C

Fig. 8.  Left Panel: Two-network module experiment showing normal responses to botulinum toxin A at 50 ng/ml and 100 ng/ml.  Irreversible loss of activity occurs at approximately 3 hrs after application.  Right Panel: Protection of exposed network by mouse antiserum.  Activity is still strong at 20 h.  Note: the two traces in the right panel are showing mean spike production (green) and mean burst production (blue) of a single network.

The left panel shows mean spike production per minute for two independent networks.  Paper in preparation.


EXAMPLE 3.  Histiotypic Mammalian Network Responses to Ethanol and Responses to Botulinum Toxin A.

 

 

EXAMPLE 4.  Pharmacologically Induced Different Network States (Spike and Burst Patterns)

 

 


Fig. 9.  Network exposure to 11 different pharmacological states results in reliable pattern changes expressed here as clusters of burst rate plotted against burst duration. The native raster plot and that for a much more organized burst oscillation state (induced by blocking all synapses except NMDA synapses) are shown in the panels to the right.  State 11 at different Ca++ concentrations is expanded in B.

 

From Keefer, Grawowski and Gross (2001) J. Neurophysiol.

 

 

 

 

 

 


EXAMPLE 5.  Quantitative Pharmacology:  Determination of Dissociation Constants

 

Determination of Kd values for the GABAA receptor blockers bicuculline, gabazene, and

Figure 10.  (A) Concentration response curves of the normalized data in absence and in the presence of 10, 20, 40, 80 µM of bicuculline. Vertical bar represented mean and SEM of spike activity change.  (B):  Schild plot of log (dose ratio-1) vs log bicuculline concentration (Molar) for the antagonism of muscimol. The fitted solid line is determined by a linear (least square) fit without slope constraint. PA2=6.3, Kd=0.52 µM

 

 


trimethylol propanephosphate.

 

B


Figure 11.  (A) Muscimol titration in the presence of  0, 10, 20, 40 µM of gabazine. Vertical bars represent mean and SEM of spike activity change. (B):  Schild plot of log (dose ratio-1) vrs log gabazine concentration (M) for the antagonism of muscimol. Linear fit (least square) without slope constraint.    PA2=7.9, Kd=0.015 µM

 

 

B

A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


                      

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 12.    Environmental chamber enclosing liquid handling robot.  Chamber maintains sterility, 10% CO2 for pH control , constant humidity, constant temperature.  Oxygen levels can also be controlled.

 

Left:  Preliminary tests with two-chamber module and 64 preamplifiers.


Fig. 13.  Preliminary data from robotic pharmacological experiments.  72 hour robot manipulation of a single network in an environmental chamber.  The panel shows 10 cycles of medium changes with 40 uM bicuculline and titration with muscimol.  Program manipulations caused some response profile changes (e.g. cycle 3).  System noise (N), is caused by stepping motors and some vibrations of amplifiers during robot movement. Improvements in programs, noise abatement, and mixing of test substance with medium should provide almost identical response profiles.  All data points represent “minute means” (all discriminated, digitized units averaged in one minute bins).  Bicuculline was added to wash medium pool before experiment.

 

1

2

3

4

5

6

7

8

9

10

EXAMPLE 6.  Robotic culture maintenance.



 

mm

Fig. 14.  Design of 8-network array plate  (glass with transparent indium-tin oxide conductors) and first electrophysiological recording on a microscope stage (Dec 24, 2005).  Note only two 32-channel preamplifiers were available.


EXAMPLE 7.  8-Network Array Design and First Recording

First simultaneous multinetwork pharmacology experiment

(Dr. Edward Keefer, UT Southwestern Medical Center using CNNS facilities)

 

 

Control                                                      25 mM carbachol                                       25 mM carbachol + 25 mM scopolamine    25 mM carbachol + 10 mM dopamine       25 mM carbachol + 10 mM risperidone

Left: 8-network assembly with 8 VLSI  preamplifier modules for 32 channels each. Above. 5-network simultaneous recording


 

20 mM bicuculline